Article
Journal Publications
2015-03-24 13:51:43|publisher: admin| Views: 2645





1. Wang, Y., T. Qian, G. You, X. Peng, C. Chen, Y. You, K. Yao, C. Wu, J. Ma, Z. Sha, S. Wang, and T. Jiang, Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping[J]. Neuro Oncol, 2015. 17(2): 282-8.

2. Zou, Y., Q. Wang, B. Li, B. Xie, and W. Wang, Temozolomide induces autophagy via ATMAMPKULK1 pathways in glioma[J]. Mol Med Rep, 2014. 10(1): 411-6.

3. Zheng, Q., L. Han, Y. Dong, J. Tian, W. Huang, Z. Liu, X. Jia, T. Jiang, J. Zhang, X. Li, C. Kang, and H. Ren, JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma[J]. Neuro Oncol, 2014. 16(9): 1229-43.

4. Zhang, T., Y. Wang, X. Fan, J. Ma, S. Li, T. Jiang, and L. Wang, Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas[J]. J Neurol Sci, 2014.

5. Zhang, K.L., X. Zhou, L. Han, L.Y. Chen, L.C. Chen, Z.D. Shi, M. Yang, Y. Ren, J.X. Yang, T.S. Frank, C.B. Zhang, J.X. Zhang, P.Y. Pu, J.N. Zhang, T. Jiang, E.J. Wagner, M. Li, and C.S. Kang, MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab[J]. Mol Cancer, 2014. 13: 63.

6. Zhang, K.L., L. Han, L.Y. Chen, Z.D. Shi, M. Yang, Y. Ren, L.C. Chen, J.X. Zhang, P.Y. Pu, and C.S. Kang, Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas[J]. Cancer Lett, 2014. 342(1): 139-49.

7. Zhang, C.B., Z.S. Bao, H.J. Wang, W. Yan, Y.W. Liu, M.Y. Li, W. Zhang, L. Chen, and T. Jiang, Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China[J]. J Cancer Res Clin Oncol, 2014. 140(1): 45-51.

8. Zhang, C., C. Li, J. Li, J. Han, D. Shang, Y. Zhang, W. Zhang, Q. Yao, L. Han, Y. Xu, W. Yan, Z. Bao, G. You, T. Jiang, C. Kang, and X. Li, Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure[J]. PLoS One, 2014. 9(5): e96908.

9. Yang, P., G. You, W. Zhang, Y. Wang, K. Yao, and T. Jiang, Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: A report of 198 patients from China[J]. Seizure, 2014.

10. Yan, W., R. Li, Y. Liu, P. Yang, Z. Wang, C. Zhang, Z. Bao, W. Zhang, Y. You, and T. Jiang, MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis[J]. Oncotarget, 2014. 5(24): 12908-15.

11. Wang, Y.Y., T. Zhang, S.W. Li, T.Y. Qian, X. Fan, X.X. Peng, J. Ma, L. Wang, and T. Jiang, Mapping p53 Mutations in Low-Grade Glioma: A Voxel-Based Neuroimaging Analysis[J]. AJNR Am J Neuroradiol, 2014.

12. Wang, Y., T. Zhang, S. Li, X. Fan, J. Ma, L. Wang, and T. Jiang, Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas[J]. Eur J Neurol, 2014.

13. Wang, Y., X. Fan, C. Zhang, T. Zhang, X. Peng, T. Qian, J. Ma, L. Wang, S. Li, and T. Jiang, Identifying radiographic specificity for phosphatase and tensin homolog and epidermal growth factor receptor changes: a quantitative analysis of glioblastomas[J]. Neuroradiology, 2014. 56(12): 1113-20.

14. Wang, Y., X. Fan, C. Zhang, T. Zhang, X. Peng, S. Li, L. Wang, J. Ma, and T. Jiang, Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas[J]. J Neurooncol, 2014. 120(2): 331-7.

15. Wang, Y., X. Chen, Z. Zhang, S. Li, B. Chen, C. Wu, L. Wang, X. Zhang, J. Wang, L. Chen, and T. Jiang, Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma[J]. Neurosurg Rev, 2014. 37(1): 73-8.

16. Tao, T., Y. Shi, D. Han, W. Luan, J. Qian, J. Zhang, Y. Wang, Y. You, and G. Chinese Glioma Cooperative, TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas[J]. Tumour Biol, 2014. 35(9): 9053-9.

17. Sun, Y., W. Zhang, D. Chen, Y. Lv, J. Zheng, H. Lilljebjorn, L. Ran, Z. Bao, C. Soneson, H.O. Sjogren, L.G. Salford, J. Ji, P.J. French, T. Fioretos, T. Jiang, and X. Fan, A glioma classification scheme based on coexpression modules of EGFR and PDGFRA[J]. Proc Natl Acad Sci U S A, 2014. 111(9): 3538-43.

18. Shi, Z.D., X.M. Qian, J.X. Zhang, L. Han, K.L. Zhang, L.Y. Chen, X. Zhou, J.N. Zhang, and C.S. Kang, BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated beta-catenin signaling[J]. CNS Neurosci Ther, 2014. 20(9): 830-9.

19. Shi, Y., Y. Wang, W. Luan, P. Wang, T. Tao, J. Zhang, J. Qian, N. Liu, and Y. You, Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675[J]. PLoS One, 2014. 9(1): e86295.

20. Liu, Y., H. Hu, K. Wang, C. Zhang, Y. Wang, K. Yao, P. Yang, L. Han, C. Kang, W. Zhang, and T. Jiang, Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas[J]. Oncotarget, 2014.

21. Lin, N., W. Yan, K. Gao, Y. Wang, J. Zhang, and Y. You, Prevalence and clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 cases[J]. PLoS One, 2014. 9(4): e94871.

22. Li, R., J. Qian, Y.Y. Wang, J.X. Zhang, and Y.P. You, Long noncoding RNA profiles reveal three molecular subtypes in glioma[J]. CNS Neurosci Ther, 2014. 20(4): 339-43.

23. Li, R., X. Li, S. Ning, J. Ye, L. Han, C. Kang, and X. Li, Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, beta-Catenin, CBP, and STAT3[J]. PLoS One, 2014. 9(7): e101903.

24. Li, R., K. Gao, H. Luo, X. Wang, Y. Shi, Q. Dong, W. Luan, and Y. You, Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma[J]. J Exp Clin Cancer Res, 2014. 33: 9.

25. Guo, T., Y. Feng, Q. Liu, X. Yang, T. Jiang, Y. Chen, and Q. Zhang, MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R[J]. Tumour Biol, 2014.

26. Feng, Y., Z. Wang, Z. Bao, W. Yan, G. You, Y. Wang, H. Hu, W. Zhang, Q. Zhang, and T. Jiang, SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients[J]. PLoS One, 2014. 9(3): e91829.

27. Fan, X., Y.Y. Wang, C.B. Zhang, G. You, M.Y. Li, L. Wang, and T. Jiang, Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas[J]. J Cancer Res Clin Oncol, 2014.

28. Chen, L., K. Zhang, Z. Shi, A. Zhang, Z. Jia, G. Wang, P. Pu, C. Kang, and L. Han, A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo[J]. Oncol Rep, 2014. 31(4): 1573-80.

29. Chen, D., D. Zuo, C. Luan, M. Liu, M. Na, L. Ran, Y. Sun, A. Persson, E. Englund, L.G. Salford, E. Renstrom, X. Fan, and E. Zhang, Glioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRA[J]. PLoS One, 2014. 9(1): e87281.

30. Cao, L., P. Wang, H. Luo, X.R. Wang, X.F. Wang, J.X. Zhang, Y.Y. Wang, L. Yao, N. Liu, and Y.P. You, Inhibition of activated Ras suppresses multiple oncogenic Hub genes in human epithelial tumors[J]. Int J Oncol, 2014. 45(4): 1609-17.

31. Cai, J., P. Yang, C. Zhang, W. Zhang, Y. Liu, Z. Bao, X. Liu, W. Du, H. Wang, T. Jiang, and C. Jiang, ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples[J]. Oncotarget, 2014. 5(9): 2551-61.

32. Bao, Z.S., G. You, W.B. Li, and T. Jiang, A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy[J]. World J Surg Oncol, 2014. 12(1): 181.

33. Bao, Z.S., M.Y. Li, J.Y. Wang, C.B. Zhang, H.J. Wang, W. Yan, Y.W. Liu, W. Zhang, L. Chen, and T. Jiang, Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling[J]. CNS Neurosci Ther, 2014. 20(2): 112-8.

34. Bao, Z.S., H.M. Chen, M.Y. Yang, C.B. Zhang, K. Yu, W.L. Ye, B.Q. Hu, W. Yan, W. Zhang, J. Akers, V. Ramakrishnan, J. Li, B. Carter, Y.W. Liu, H.M. Hu, Z. Wang, M.Y. Li, K. Yao, X.G. Qiu, C.S. Kang, Y.P. You, X.L. Fan, W.S. Song, R.Q. Li, X.D. Su, C.C. Chen, and T. Jiang, RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas[J]. Genome Res, 2014. 24(11): 1765-73.

35. Bao, Z., Y. Feng, H. Wang, C. Zhang, L. Sun, Z. Yan, Q. Liu, T. Guo, M. Li, X. Yang, C. Jiang, Q. Zhang, and T. Jiang, Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma[J]. Oncol Rep, 2014. 32(1): 250-60.

36. Zhao, P., P. Zou, L. Zhao, W. Yan, C. Kang, T. Jiang, and Y. You, Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility[J]. BMC Cancer, 2013. 13: 234.

37. Zhang, W., J. Zhang, W. Yan, G. You, Z. Bao, S. Li, C. Kang, C. Jiang, Y. You, Y. Zhang, C.C. Chen, S.W. Song, and T. Jiang, Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme[J]. Cancer, 2013. 119(4): 814-24.

38. Zhang, W., W. Yan, G. You, Z. Bao, Y. Wang, Y. Liu, Y. You, and T. Jiang, Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma[J]. Cancer Lett, 2013. 328(1): 120-5.

39. Zhang, J.X., J. Zhang, W. Yan, Y.Y. Wang, L. Han, X. Yue, N. Liu, Y.P. You, T. Jiang, P.Y. Pu, and C.S. Kang, Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma[J]. Neuro Oncol, 2013. 15(3): 279-89.

40. Zhang, J.X., L. Han, Z.S. Bao, Y.Y. Wang, L.Y. Chen, W. Yan, S.Z. Yu, P.Y. Pu, N. Liu, Y.P. You, T. Jiang, and C.S. Kang, HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma[J]. Neuro Oncol, 2013. 15(12): 1595-603.

41. You, G., L. Feng, W. Yan, W. Zhang, Y.Z. Wang, S.W. Li, S.W. Li, G.L. Li, Y.J. Song, C.S. Kang, Y.P. You, and T. Jiang, BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas[J]. CNS Neurosci Ther, 2013. 19(11): 882-8.

42. Yang, P., Y. Wang, X. Peng, G. You, W. Zhang, W. Yan, Z. Bao, Y. Wang, X. Qiu, and T. Jiang, Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution[J]. J Neurooncol, 2013. 113(2): 259-66.

43. Yan, Z.H., Z.S. Bao, W. Yan, Y.W. Liu, C.B. Zhang, H.J. Wang, Y. Feng, Y.Z. Wang, W. Zhang, G. You, Q.G. Zhang, and T. Jiang, Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype[J]. Curr Mol Med, 2013. 13(3): 438-45.

44. Wang, Z., Z. Bao, W. Yan, G. You, Y. Wang, X. Li, and W. Zhang, Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type[J]. J Exp Clin Cancer Res, 2013. 32: 59.

45. Wang, Y. and T. Jiang, Understanding high grade glioma: molecular mechanism, therapy and comprehensive management[J]. Cancer Lett, 2013. 331(2): 139-46.

46. Wang, X.R., H. Luo, H.L. Li, L. Cao, X.F. Wang, W. Yan, Y.Y. Wang, J.X. Zhang, T. Jiang, C.S. Kang, N. Liu, and Y.P. You, Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN[J]. Neuro Oncol, 2013. 15(11): 1491-501.

47. Wang, X., Y.Y. Wang, T. Jiang, Y.Z. Wang, and C.X. Wu, Direct evidence of the left caudate's role in bilingual control: an intra-operative electrical stimulation study[J]. Neurocase, 2013. 19(5): 462-9.

48. Wang, X., K. Wang, L. Han, A. Zhang, Z. Shi, K. Zhang, H. Zhang, S. Yang, P. Pu, C. Shen, C. Yu, and C. Kang, PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/beta-catenin pathway in a Dkk1-dependent manner during glioma growth[J]. Cancer Lett, 2013. 331(2): 211-9.

49. Wang, L.J., Y. Bai, Z.S. Bao, Y. Chen, Z.H. Yan, W. Zhang, and Q.G. Zhang, Hypermethylation of testis derived transcript gene promoter significantly correlates with worse outcomes in glioblastoma patients[J]. Chin Med J (Engl), 2013. 126(11): 2062-6.

50. Tao, T., Y. Wang, H. Luo, L. Yao, L. Wang, J. Wang, W. Yan, J. Zhang, H. Wang, Y. Shi, Y. Yin, T. Jiang, C. Kang, N. Liu, and Y. You, Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas[J]. Eur J Cancer, 2013. 49(14): 3055-63.

51. Shi, Z.M., X.F. Wang, X. Qian, T. Tao, L. Wang, Q.D. Chen, X.R. Wang, L. Cao, Y.Y. Wang, J.X. Zhang, T. Jiang, C.S. Kang, B.H. Jiang, N. Liu, and Y.P. You, MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas[J]. RNA, 2013. 19(4): 552-60.

52. Shi, Z.D., X.M. Qian, C.Y. Liu, L. Han, K.L. Zhang, L.Y. Chen, J.X. Zhang, P.Y. Pu, X.B. Yuan, and C.S. Kang, Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of beta-catenin transactivation[J]. CNS Neurosci Ther, 2013. 19(2): 98-108.

53. Shi, Z., J. Zhang, X. Qian, L. Han, K. Zhang, L. Chen, J. Liu, Y. Ren, M. Yang, A. Zhang, P. Pu, and C. Kang, AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression[J]. Cancer Res, 2013. 73(17): 5519-31.

54. Liu, Y., K. Tang, W. Yan, Y. Wang, G. You, C. Kang, T. Jiang, and W. Zhang, Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas[J]. Neurosci Lett, 2013. 546: 36-41.

55. Li, Y., J. Xu, H. Chen, J. Bai, S. Li, Z. Zhao, T. Shao, T. Jiang, H. Ren, C. Kang, and X. Li, Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression[J]. Nucleic Acids Res, 2013. 41(22): e203.

56. Li, W.B., H.Y. Chen, W. Zhang, W. Yan, R. Shi, S.W. Li, and T. Jiang, Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme[J]. Chin Med J (Engl), 2013. 126(15): 2881-5.

57. Gong, F., G. Wang, J. Ye, T. Li, H. Bai, and W. Wang, 14-3-3beta regulates the proliferation of glioma cells through the GSK3beta/beta-catenin signaling pathway[J]. Oncol Rep, 2013. 30(6): 2976-82.

58. Chen, Y.D., X. Zhang, X.G. Qiu, J. Li, Q. Yuan, T. Jiang, and M. Yang, Functional FEN1 genetic variants and haplotypes are associated with glioma risk[J]. J Neurooncol, 2013. 111(2): 145-51.

59. Chen, L., A. Zhang, Y. Li, K. Zhang, L. Han, W. Du, W. Yan, R. Li, Y. Wang, K. Wang, P. Pu, T. Jiang, C. Jiang, and C. Kang, MiR-24 regulates the proliferation and invasion of glioma by ST7L via beta-catenin/Tcf-4 signaling[J]. Cancer Lett, 2013. 329(2): 174-80.

60. Chen, D., A. Persson, Y. Sun, L.G. Salford, D.G. Nord, E. Englund, T. Jiang, and X. Fan, Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis[J]. PLoS One, 2013. 8(4): e61556.

61. Bao, Z.S., C.B. Zhang, H.J. Wang, W. Yan, Y.W. Liu, M.Y. Li, and W. Zhang, Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme[J]. CNS Neurosci Ther, 2013. 19(9): 714-20.

62. Bao, Z., C. Zhang, W. Yan, Y. Liu, M. Li, W. Zhang, and T. Jiang, BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas[J]. J Transl Med, 2013. 11: 100.

63. Zhao, P., L. Zhao, P. Zou, A. Lu, N. Liu, W. Yan, C. Kang, Z. Fu, Y. You, and T. Jiang, Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study[J]. BMC Cancer, 2012. 12: 617.

64. Zhang, W., J. Zhang, K. Hoadley, D. Kushwaha, V. Ramakrishnan, S. Li, C. Kang, Y. You, C. Jiang, S.W. Song, T. Jiang, and C.C. Chen, miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression[J]. Neuro Oncol, 2012. 14(6): 712-9.

65. Zhang, K., J. Zhang, L. Han, P. Pu, and C. Kang, Wnt/beta-catenin signaling in glioma[J]. J Neuroimmune Pharmacol, 2012. 7(4): 740-9.

66. Zhang, J., A. Zhang, Y. Wang, N. Liu, Y. You, C. Kang, and P. Pu, New insights into the roles of ncRNA in the STAT3 pathway[J]. Future Oncol, 2012. 8(6): 723-30.

67. Zhang, C., J. Zhang, J. Hao, Z. Shi, Y. Wang, L. Han, S. Yu, Y. You, T. Jiang, J. Wang, M. Liu, P. Pu, and C. Kang, High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma[J]. J Transl Med, 2012. 10: 119.

68. You, G., W. Yan, W. Zhang, Y. Wang, Z. Bao, S. Li, S. Li, G. Li, Y. Song, C. Kang, and T. Jiang, Significance of miR-196b in tumor-related epilepsy of patients with gliomas[J]. PLoS One, 2012. 7(9): e46218.

69. You, G., Z.Y. Sha, W. Yan, W. Zhang, Y.Z. Wang, S.W. Li, L. Sang, Z. Wang, G.L. Li, S.W. Li, Y.J. Song, C.S. Kang, and T. Jiang, Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study[J]. Neuro Oncol, 2012. 14(2): 230-41.

70. You, G., Z. Sha, and T. Jiang, The pathogenesis of tumor-related epilepsy and its implications for clinical treatment[J]. Seizure, 2012. 21(3): 153-9.

71. You, G., L. Huang, P. Yang, W. Zhang, W. Yan, Y. Wang, Z. Bao, S. Li, S. Li, G. Li, and T. Jiang, Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas[J]. Eur J Neurol, 2012. 19(2): 298-306.

72. Yan, W., W. Zhang, G. You, J. Zhang, L. Han, Z. Bao, Y. Wang, Y. Liu, C. Jiang, C. Kang, Y. You, and T. Jiang, Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group[J]. Neuro Oncol, 2012. 14(12): 1432-40.

73. Yan, W., W. Zhang, G. You, Z. Bao, Y. Wang, Y. Liu, C. Kang, Y. You, L. Wang, and T. Jiang, Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China[J]. PLoS One, 2012. 7(1): e30339.

74. Wang, Y.Y., G. Sun, H. Luo, X.F. Wang, F.M. Lan, X. Yue, L.S. Fu, P.Y. Pu, C.S. Kang, N. Liu, and Y.P. You, MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth[J]. CNS Neurosci Ther, 2012. 18(9): 722-8.

75. Wang, Y., X. Wang, J. Zhang, G. Sun, H. Luo, C. Kang, P. Pu, T. Jiang, N. Liu, and Y. You, MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas[J]. J Neurooncol, 2012. 106(2): 217-24.

76. Wang, Y., S. Li, L. Chen, G. You, Z. Bao, W. Yan, Z. Shi, Y. Chen, K. Yao, W. Zhang, C. Kang, and T. Jiang, Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome[J]. Neuro Oncol, 2012. 14(4): 518-25.

77. Wang, X.F., Z.M. Shi, X.R. Wang, L. Cao, Y.Y. Wang, J.X. Zhang, Y. Yin, H. Luo, C.S. Kang, N. Liu, T. Jiang, and Y.P. You, MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2[J]. J Cancer Res Clin Oncol, 2012. 138(4): 573-84.

78. Wang, X., L. Huang, Y. Xu, Z. Shi, Y. Wang, J. Zhang, L. Cao, H. Luo, J. Chen, N. Liu, Y. Yin, and Y. You, Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis[J]. Eur J Hum Genet, 2012. 20(7): 790-5.

79. Wang, X., L. Cao, Y. Wang, N. Liu, and Y. You, Regulation of let-7 and its target oncogenes (Review)[J]. Oncol Lett, 2012. 3(5): 955-960.

80. Tang, K., Q. Jin, W. Yan, W. Zhang, G. You, Y. Liu, and T. Jiang, Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients[J]. Med Oncol, 2012. 29(2): 1292-6.

81. Shi, Z., X. Qian, L. Li, J. Zhang, S. Zhu, J. Zhu, L. Chen, K. Zhang, L. Han, S. Yu, P. Pu, T. Jiang, and C. Kang, Nuclear translocation of beta-catenin is essential for glioma cell survival[J]. J Neuroimmune Pharmacol, 2012. 7(4): 892-903.

82. Shi, L., S. Zhang, K. Feng, F. Wu, Y. Wan, Z. Wang, J. Zhang, Y. Wang, W. Yan, Z. Fu, and Y. You, MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis[J]. Int J Oncol, 2012. 40(1): 119-29.

83. Shi, L., Y. Wan, G. Sun, X. Gu, C. Qian, W. Yan, S. Zhang, T. Pan, Z. Wang, and Y. You, Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells[J]. Neuromolecular Med, 2012. 14(4): 303-16.

84. Ma, R., W. Yan, G. Zhang, H. Lv, Z. Liu, F. Fang, W. Zhang, J. Zhang, T. Tao, Y. You, T. Jiang, and X. Kang, Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype[J]. PLoS One, 2012. 7(6): e38096.

85. Ma, R., T. Jiang, and X. Kang, Circulating microRNAs in cancer: origin, function and application[J]. J Exp Clin Cancer Res, 2012. 31: 38.

86. Liu, Y., W. Yan, W. Zhang, L. Chen, G. You, Z. Bao, Y. Wang, H. Wang, C. Kang, and T. Jiang, MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1[J]. Oncol Rep, 2012. 28(3): 1013-21.

87. Li, Y., T. Jiang, J. Zhang, B. Zhang, W. Yang, G. You, K. Xu, J. Wu, C. Luo, and S.W. Song, Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies[J]. Ann Oncol, 2012. 23(9): 2415-22.

88. Li, S., C. Yan, L. Huang, X. Qiu, Z. Wang, and T. Jiang, Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China[J]. Neuro Oncol, 2012. 14(1): 109-16.

89. Lan, F., X. Yue, L. Han, Z. Shi, Y. Yang, P. Pu, Z. Yao, and C. Kang, Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer[J]. Int J Oncol, 2012. 40(2): 519-26.

90. Han, L., K. Zhang, Z. Shi, J. Zhang, J. Zhu, S. Zhu, A. Zhang, Z. Jia, G. Wang, S. Yu, P. Pu, L. Dong, and C. Kang, LncRNA pro fi le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis[J]. Int J Oncol, 2012. 40(6): 2004-12.

91. Han, L., X. Yue, X. Zhou, F.M. Lan, G. You, W. Zhang, K.L. Zhang, C.Z. Zhang, J.Q. Cheng, S.Z. Yu, P.Y. Pu, T. Jiang, and C.S. Kang, MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK[J]. CNS Neurosci Ther, 2012. 18(7): 573-83.

92. Han, L., Y. Ren, L. Long, Y. Zhong, C. Shen, P. Pu, X. Yuan, and C. Kang, Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles[J]. Oncol Rep, 2012. 27(1): 121-8.

93. Chen, Q., X.Z. Chen, J.M. Wang, S.W. Li, T. Jiang, and J.P. Dai, Intracranial meningeal hemangiopericytomas in children and adolescents: CT and MR imaging findings[J]. AJNR Am J Neuroradiol, 2012. 33(1): 195-9.

94. Chen, L., W. Zhang, W. Yan, L. Han, K. Zhang, Z. Shi, J. Zhang, Y. Wang, Y. Li, S. Yu, P. Pu, C. Jiang, T. Jiang, and C. Kang, The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma[J]. Carcinogenesis, 2012. 33(11): 2276-82.

95. Chen, L., J. Zhang, L. Han, A. Zhang, C. Zhang, Y. Zheng, T. Jiang, P. Pu, C. Jiang, and C. Kang, Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status[J]. Oncol Rep, 2012. 27(3): 854-60.

96. Chen, L., J. Zhang, Y. Feng, R. Li, X. Sun, W. Du, X. Piao, H. Wang, D. Yang, Y. Sun, X. Li, T. Jiang, C. Kang, Y. Li, and C. Jiang, MiR-410 regulates MET to influence the proliferation and invasion of glioma[J]. Int J Biochem Cell Biol, 2012. 44(11): 1711-7.

97. Chen, L., X. Wang, H. Wang, Y. Li, W. Yan, L. Han, K. Zhang, J. Zhang, Y. Wang, Y. Feng, P. Pu, T. Jiang, C. Kang, and C. Jiang, miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2[J]. Eur J Cancer, 2012. 48(16): 3104-11.

98. Chen, L., L. Han, K. Zhang, Z. Shi, J. Zhang, A. Zhang, Y. Wang, Y. Song, Y. Li, T. Jiang, P. Pu, C. Jiang, and C. Kang, VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1alpha/VEGF and beta-catenin/Tcf-4 signaling[J]. Neuro Oncol, 2012. 14(8): 1026-36.

99. Chen, L., L. Han, Z. Shi, K. Zhang, Y. Liu, Y. Zheng, T. Jiang, P. Pu, C. Jiang, and C. Kang, LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway[J]. Mol Med Rep, 2012. 5(2): 575-9.

100. Zhang, J., K. Huang, Z. Shi, J. Zou, Y. Wang, Z. Jia, A. Zhang, L. Han, X. Yue, N. Liu, T. Jiang, Y. You, P. Pu, and C. Kang, High beta-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression[J]. Neuro Oncol, 2011. 13(6): 600-9.

101. You, G., W. Yan, W. Zhang, S. Li, G. Li, and T. Jiang, Isolated angiitis of the central nervous system with tumor-like lesion, mimicking brain malignant glioma: a case report and review of the literature[J]. World J Surg Oncol, 2011. 9: 97.

102. Yan, W., W. Zhang, L. Sun, Y. Liu, G. You, Y. Wang, C. Kang, Y. You, and T. Jiang, Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme[J]. Brain Res, 2011. 1411: 108-15.

103. Yan, W., W. Zhang, and T. Jiang, Oncogene addiction in gliomas: implications for molecular targeted therapy[J]. J Exp Clin Cancer Res, 2011. 30: 58.

104. Wu, D.G., Y.Y. Wang, L.G. Fan, H. Luo, B. Han, L.H. Sun, X.F. Wang, J.X. Zhang, L. Cao, X.R. Wang, Y.P. You, and N. Liu, MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression[J]. Chin Med J (Engl), 2011. 124(17): 2616-21.

105. Wang, Y., W. Yan, X. Lu, C. Qian, J. Zhang, P. Li, L. Shi, P. Zhao, Z. Fu, P. Pu, C. Kang, T. Jiang, N. Liu, and Y. You, Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avbeta3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells[J]. Eur J Cell Biol, 2011. 90(8): 642-8.

106. Wang, Y., L. Chen, Z. Bao, S. Li, G. You, W. Yan, Z. Shi, Y. Liu, P. Yang, W. Zhang, L. Han, C. Kang, and T. Jiang, Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways[J]. Oncol Rep, 2011. 26(5): 1173-80.

107. Wang, X., L. Han, A. Zhang, G. Wang, Z. Jia, Y. Yang, X. Yue, P. Pu, C. Shen, and C. Kang, Adenovirus-mediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells[J]. Oncol Rep, 2011. 25(1): 97-105.

108. Sun, L., W. Yan, Y. Wang, G. Sun, H. Luo, J. Zhang, X. Wang, Y. You, Z. Yang, and N. Liu, MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10[J]. Brain Res, 2011. 1389: 9-18.

109. Sun, G., Y. Wang, L. Sun, H. Luo, N. Liu, Z. Fu, and Y. You, Clinical significance of Hiwi gene expression in gliomas[J]. Brain Res, 2011. 1373: 183-8.

110. Pu, S., Y.N. Li, C.X. Wu, Y.Z. Wang, X.L. Zhou, and T. Jiang, Cortical areas involved in numerical processing: an intraoperative electrostimulation study[J]. Stereotact Funct Neurosurg, 2011. 89(1): 42-7.

111. Lan, F., X. Yue, L. Han, X. Yuan, Z. Shi, K. Huang, Y. Yang, J. Zou, J. Zhang, T. Jiang, P. Pu, and C. Kang, Antitumor effect of aspirin in glioblastoma cells by modulation of beta-catenin/T-cell factor-mediated transcriptional activity[J]. J Neurosurg, 2011. 115(4): 780-8.

112. Jin, Q., W. Zhang, X.G. Qiu, W. Yan, G. You, Y.W. Liu, T. Jiang, and L. Wang, Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma[J]. Chin Med J (Engl), 2011. 124(17): 2584-8.

113. Jiang, T., G.F. Tang, Y. Lin, X.X. Peng, X. Zhang, X.W. Zhai, X. Peng, J.Q. Yang, H.E. Huang, N.F. Wu, X.J. Chen, H.X. Xing, T.Y. Su, and Z.C. Wang, Prevalence estimates for primary brain tumors in China: a multi-center cross-sectional study[J]. Chin Med J (Engl), 2011. 124(17): 2578-83.

114. Huang, L., G. You, T. Jiang, G. Li, S. Li, and Z. Wang, Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study[J]. J Neurol Sci, 2011. 302(1-2): 63-7.

115. Chen, L., H. Li, L. Han, K. Zhang, G. Wang, Y. Wang, Y. Liu, Y. Zheng, T. Jiang, P. Pu, C. Jiang, and C. Kang, Expression and function of miR-27b in human glioma[J]. Oncol Rep, 2011. 26(6): 1617-21.

116. Chen, L., K. Huang, L. Han, Z. Shi, K. Zhang, P. Pu, C. Jiang, and C. Kang, beta-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma[J]. Int J Oncol, 2011. 39(4): 883-90.

117. Bai, H.M., W.M. Wang, T.D. Li, H. He, C. Shi, X.F. Guo, Y. Liu, L.M. Wang, and S.S. Wang, Three core techniques in surgery of neuroepithelial tumors in eloquent areas: awake anaesthesia, intraoperative direct electrical stimulation and ultrasonography[J]. Chin Med J (Engl), 2011. 124(19): 3035-41.

118. Zhou, X., J. Zhang, Q. Jia, Y. Ren, Y. Wang, L. Shi, N. Liu, G. Wang, P. Pu, Y. You, and C. Kang, Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3[J]. Oncol Rep, 2010. 24(1): 195-201.

119. Zhou, X., Y. Ren, L. Moore, M. Mei, Y. You, P. Xu, B. Wang, G. Wang, Z. Jia, P. Pu, W. Zhang, and C. Kang, Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status[J]. Lab Invest, 2010. 90(2): 144-55.

120. Zhou, X., Y. Ren, L. Han, M. Mei, P. Xu, C.Z. Zhang, G.X. Wang, Z.F. Jia, P.Y. Pu, and C.S. Kang, Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells[J]. Int J Oncol, 2010. 36(3): 665-72.

121. Zhang, W., Y. Lin, B. Chen, S.W. Song, and T. Jiang, Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features[J]. Childs Nerv Syst, 2010. 26(1): 137-43.

122. Zhang, J.X., C.S. Kang, L. Shi, P. Zhao, N. Liu, and Y.P. You, Use of thymidine kinase gene-modified endothelial progenitor cells as a vector targeting angiogenesis in glioma gene therapy[J]. Oncology, 2010. 78(2): 94-102.

123. Zhang, J., L. Han, A. Zhang, Y. Wang, X. Yue, Y. You, P. Pu, and C. Kang, AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion[J]. Oncol Rep, 2010. 24(1): 65-72.

124. Zhang, J., L. Han, Y. Ge, X. Zhou, A. Zhang, C. Zhang, Y. Zhong, Y. You, P. Pu, and C. Kang, miR-221/222 promote malignant progression of glioma through activation of the Akt pathway[J]. Int J Oncol, 2010. 36(4): 913-20.

125. Zhang, C.Z., J.X. Zhang, A.L. Zhang, Z.D. Shi, L. Han, Z.F. Jia, W.D. Yang, G.X. Wang, T. Jiang, Y.P. You, P.Y. Pu, J.Q. Cheng, and C.S. Kang, MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma[J]. Mol Cancer, 2010. 9: 229.

126. Zhang, C., J. Zhang, A. Zhang, Y. Wang, L. Han, Y. You, P. Pu, and C. Kang, PUMA is a novel target of miR-221/222 in human epithelial cancers[J]. Int J Oncol, 2010. 37(6): 1621-6.

127. Zhang, C., L. Han, A. Zhang, W. Yang, X. Zhou, P. Pu, Y. Du, H. Zeng, and C. Kang, Global changes of mRNA expression reveals an increased activity of the interferon-induced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells[J]. Int J Oncol, 2010. 36(6): 1503-12.

128. Yue, X., F. Lan, W. Yang, Y. Yang, L. Han, A. Zhang, J. Liu, H. Zeng, T. Jiang, P. Pu, and C. Kang, Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells[J]. Brain Res, 2010. 1366: 27-37.

129. Yan, W., C. Qian, P. Zhao, J. Zhang, L. Shi, J. Qian, N. Liu, Z. Fu, C. Kang, P. Pu, and Y. You, Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells[J]. Neuro Oncol, 2010. 12(8): 765-75.

130. Shi, L., J. Zhang, T. Pan, J. Zhou, W. Gong, N. Liu, Z. Fu, and Y. You, MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation[J]. Brain Res, 2010. 1312: 120-6.

131. Ren, Y., X. Zhou, M. Mei, X.B. Yuan, L. Han, G.X. Wang, Z.F. Jia, P. Xu, P.Y. Pu, and C.S. Kang, MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol[J]. BMC Cancer, 2010. 10: 27.

132. Li, S.W., J.F. Wang, T. Jiang, S.W. Li, W.B. Zhang, Z.X. Li, Z. Zhang, J.P. Dai, and Z.C. Wang, Preoperative 3T high field blood oxygen level dependent functional magnetic resonance imaging for glioma involving sensory cortical areas[J]. Chin Med J (Engl), 2010. 123(8): 1006-10.

133. Li, S., W. Zhang, B. Chen, T. Jiang, and Z. Wang, Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy[J]. Neurol Res, 2010. 32(7): 690-4.

134. Kang, C., X. Yuan, F. Li, P. Pu, S. Yu, C. Shen, Z. Zhang, and Y. Zhang, Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo[J]. J Biomed Mater Res A, 2010. 93(2): 585-94.

135. Huang, K., J.X. Zhang, L. Han, Y.P. You, T. Jiang, P.Y. Pu, and C.S. Kang, MicroRNA roles in beta-catenin pathway[J]. Mol Cancer, 2010. 9: 252.

136. Han, L., A.L. Zhang, P. Xu, X. Yue, Y. Yang, G.X. Wang, Z.F. Jia, P.Y. Pu, and C.S. Kang, Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo[J]. Med Oncol, 2010. 27(3): 843-52.

137. Han, L., A. Zhang, X. Zhou, P. Xu, G.X. Wang, P.Y. Pu, and C.S. Kang, Downregulation of Dicer enhances tumor cell proliferation and invasion[J]. Int J Oncol, 2010. 37(2): 299-305.

138. Han, L., Y. Yang, X. Yue, K. Huang, X. Liu, P. Pu, H. Jiang, W. Yan, T. Jiang, and C. Kang, Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of beta-catenin-mediated transcription[J]. Brain Res, 2010. 1366: 9-17.

139. Chen, X., J. Dai, and T. Jiang, Supratentorial WHO grade II glioma invasion: a morphologic study using sequential conventional MRI[J]. Br J Neurosurg, 2010. 24(2): 196-201.

140. Zhang, W., X.G. Qiu, B.S. Chen, S.W. Li, Y. Cui, H. Ren, and T. Jiang, Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations[J]. Chin Med J (Engl), 2009. 122(11): 1250-4.

141. Zhang, J., B. Liu, X. Jiang, H. Zhao, M. Fan, Z. Fan, J.J. Lee, T. Jiang, and S.W. Song, A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors[J]. PLoS One, 2009. 4(7): e6274.

142. Zhang, C., C. Kang, Y. You, P. Pu, W. Yang, P. Zhao, G. Wang, A. Zhang, Z. Jia, L. Han, and H. Jiang, Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo[J]. Int J Oncol, 2009. 34(6): 1653-60.

143. Qian, C.F., W. Yan, J.X. Zhang, L. Shi, J. Qian, Z. Fu, C.S. Kang, N. Liu, and Y.P. You, Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line[J]. Int J Mol Med, 2009. 24(4): 445-51.

144. Lu, X., P. Zhao, C. Zhang, Z. Fu, Y. Chen, A. Lu, N. Liu, Y. You, P. Pu, and C. Kang, Analysis of miR-221 and p27 expression in human gliomas[J]. Mol Med Rep, 2009. 2(4): 651-6.

145. Lin, Y., T. Jiang, K. Zhou, L. Xu, B. Chen, G. Li, X. Qiu, T. Jiang, W. Zhang, and S.W. Song, Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas[J]. Neuro Oncol, 2009. 11(5): 468-76.

146. Li, S.W., X.G. Qiu, B.S. Chen, W. Zhang, H. Ren, Z.C. Wang, and T. Jiang, Prognostic factors influencing clinical outcomes of glioblastoma multiforme[J]. Chin Med J (Engl), 2009. 122(11): 1245-9.

147. Li, S.W. and T. Jiang, Advances in the adjuvant chemotherapy of glioblastoma multiforme: opportunities and challenges for the neurosurgeons in China[J]. Chin Med J (Engl), 2009. 122(11): 1243-4.

148. Kang, C., X. Yuan, Y. Zhong, P. Pu, Y. Guo, A. Albadany, S. Yu, Z. Zhang, Y. Li, J. Chang, and J. Sheng, Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles[J]. Technol Cancer Res Treat, 2009. 8(1): 61-70.

149. Huang, L., T. Jiang, F. Yuan, G.L. Li, Y. Cui, E.Z. Liu, and Z.C. Wang, Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study[J]. Neuropathol Appl Neurobiol, 2009. 35(4): 367-79.

150. Zhang, Z., T. Jiang, J. Xie, F.S. Liu, S.W. Li, H. Qiao, and Z.C. Wang, Surgical strategies for glioma involving language areas[J]. Chin Med J (Engl), 2008. 121(18): 1800-5.

151. Zhang, J., P. Zhao, Z. Fu, X. Chen, N. Liu, A. Lu, R. Li, L. Shi, P. Pu, C. Kang, and Y. You, Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1[J]. Oncol Rep, 2008. 20(6): 1457-63.

152. Xie, J., X.Z. Chen, T. Jiang, S.W. Li, Z.X. Li, Z. Zhang, J.P. Dai, and Z.C. Wang, Preoperative blood oxygen level-dependent functional magnetic resonance imaging in patients with gliomas involving the motor cortical areas[J]. Chin Med J (Engl), 2008. 121(7): 631-5.

153. Wu, C.X., S. Pu, Y. Lin, Y.Z. Wang, T. Jiang, J. Xie, M. Wei, X.L. Yi, and X.Y. Wang, Fractionated resection on low grade gliomas involving Broca's area and insights to brain plasticity[J]. Chin Med J (Engl), 2008. 121(20): 2026-30.

154. Shi, L., Z. Cheng, J. Zhang, R. Li, P. Zhao, Z. Fu, and Y. You, hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells[J]. Brain Res, 2008. 1236: 185-93.

155. Li, S., T. Jiang, G. Li, and Z. Wang, Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results[J]. Neurol Res, 2008. 30(6): 567-70.

156. Huang, L., T. Jiang, F. Yuan, G.L. Li, E.Z. Liu, and Z.C. Wang, Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors[J]. Clin Neurol Neurosurg, 2008. 110(10): 1020-4.

157. Chen, X.Z., T. Jiang, S.W. Li, L. Ai, and J.P. Dai, Dynamic radiological change of gliomas located in the paralimbic system and its clinical significance[J]. Chin Med J (Engl), 2008. 121(8): 713-5.

158. You, Y., X. Geng, P. Zhao, Z. Fu, C. Wang, S. Chao, N. Liu, A. Lu, K. Gardner, P. Pu, C. Kong, Y. Ge, S.I. Judge, and Q.Q. Li, Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts[J]. Cell Mol Life Sci, 2007. 64(5): 621-31.

159. Tian, L., T. Jiang, M. Liang, X. Li, Y. He, K. Wang, B. Cao, and T. Jiang, Stabilities of negative correlations between blood oxygen level-dependent signals associated with sensory and motor cortices[J]. Hum Brain Mapp, 2007. 28(7): 681-90.

160. Huang, Q., P. Pu, Z. Xia, and Y. You, Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells[J]. J Neurooncol, 2007. 82(3): 239-48.

161. You, Y., P. Pu, Q. Huang, Z. Xia, C. Wang, G. Wang, C. Yu, J.J. Yu, E. Reed, and Q.Q. Li, Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo[J]. Int J Oncol, 2006. 28(5): 1225-32.

162. Kang, C.S., Z.Y. Zhang, Z.F. Jia, G.X. Wang, M.Z. Qiu, H.X. Zhou, S.Z. Yu, J. Chang, H. Jiang, and P.Y. Pu, Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo[J]. Cancer Gene Ther, 2006. 13(5): 530-8.

 


Related Categories
News
HOT